82 FR 44821 - National Heart, Lung, and Blood Institute; Notice of Closed Meeting

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health

Federal Register Volume 82, Issue 185 (September 26, 2017)

Page Range		44821-44821
FR Document		2017-20489

Federal Register, Volume 82 Issue 185 (Tuesday, September 26, 2017)

[Federal Register Volume 82, Number 185 (Tuesday, September 26, 2017)]
[Notices]
[Page 44821]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2017-20489]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Heart, Lung, and Blood Institute; Notice of Closed 
Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of a meeting of the NHLBI Special 
Emphasis Panel.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Heart, Lung, and Blood Institute 
Special Emphasis Panel; Grant Review for NHLBI K Award Recipients.
    Date: October 17, 2017.
    Time: 12:00 p.m. to 4:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6701 Rockledge Drive, 
Suite 7202, Bethesda, MD 20892 (Telephone Conference Call).
    Contact Person: Melissa E Nagelin, Ph.D., Scientific Review 
Officer, Office of Scientific Review/DERA, National Heart, Lung, and 
Blood Institute, 6701 Rockledge Drive, Room 7202, Bethesda, MD 
20892, 301-435-0297, [email protected].

(Catalogue of Federal Domestic Assistance Program Nos. 93.233, 
National Center for Sleep Disorders Research; 93.837, Heart and 
Vascular Diseases Research; 93.838, Lung Diseases Research; 93.839, 
Blood Diseases and Resources Research, National Institutes of 
Health, HHS)

    Dated: September 20, 2017.
Michelle Trout,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2017-20489 Filed 9-25-17; 8:45 am]
 BILLING CODE 4140-01-P

Federal Register / Vol. 82, No. 185 / Tuesday, September 26, 2017 / Notices 44821

surveillance systems to monitor HIV/ reasonable accommodations, should DEPARTMENT OF HEALTH AND
HCV coinfections among low-income or notify the Contact Person listed below HUMAN SERVICES
underinsured, racial and ethnic in advance of the meeting. The meeting
minority populations. HRSA–17–047 will also be videocast and can be National Institutes of Health
recipients and subrecipients will require accessed from the NIH Videocasting and
similar evaluation and technical National Heart, Lung, and Blood
Podcasting Web site (http://
assistance in order to meet the Institute; Notice of Closed Meeting
videocast.nih.gov/).
program’s goals and objectives. Pursuant to section 10(d) of the
Supplemental funding to the existing Name of Committee: Frederick National
Laboratory Advisory Committee to the Federal Advisory Committee Act, as
ETAC is a cost effective and efficient amended, notice is hereby given of a
solution that will leverage RAND National Cancer Institute
Date: October 30, 2017. meeting of the NHLBI Special Emphasis
Corporation’s currently funded Panel.
infrastructure to include the additional Time: 9:00 a.m. to 5:00 p.m.
Agenda: Ongoing and new activities at the The meeting will be closed to the
sites funded under HRSA–17–047. public in accordance with the
Further, this supplemental funding will Frederick National Laboratory for Cancer
Research. provisions set forth in sections
leverage RAND’s current work by 552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
combining and comparing evaluation Place: National Institutes of Health, 31
Center Drive, Building 31, Wing C; 6th Floor, as amended. The grant applications and
results across all jurisdictions from both the discussions could disclose
Conference Room 10, Bethesda, MD 20892.
initiatives and facilitate the streamlining
Contact Person: Caron A. Lyman, Ph.D. confidential trade secrets or commercial
and integration of processes and
Executive Secretary, National Cancer property such as patentable material,
technical assistance. Supplemental
Institute, National Institutes of Health, 9609 and personal information concerning
funding will also provide opportunities
Medical Center Drive, Room 7W–126, individuals associated with the grant
for RAND Corporation to create joint
Bethesda, MD 20892, 240–276–6348 applications, the disclosure of which
learning networks and build on lessons
lymanc@mail.nih.gov. would constitute a clearly unwarranted
learned from the initial cohort of
Any interested person may file written invasion of personal privacy.
jurisdictional sites currently in the
second year of implementation. Not comments with the committee by forwarding Name of Committee: National Heart, Lung,
issuing this award would result in a lack the statement to the Contact Person listed on and Blood Institute Special Emphasis Panel;
of evaluation and technical assistance this notice. The statement should include the Grant Review for NHLBI K Award Recipients.
name, address, telephone number and when Date: October 17, 2017.
for HRSA–17–047 recipients and
applicable, the business or professional Time: 12:00 p.m. to 4:00 p.m.
subrecipients, which is critical to Agenda: To review and evaluate grant
achieving the initiative’s goal to cure affiliation of the interested person.
In the interest of security, NIH has applications.
HCV among HIV/HCV coinfected people Place: National Institutes of Health, 6701
of color. instituted stringent procedures for entrance
Rockledge Drive, Suite 7202, Bethesda, MD
onto the NIH campus. All visitor vehicles, 20892 (Telephone Conference Call).
FOR FURTHER INFORMATION CONTACT: Mr.
including taxicabs, hotel, and airport shuttles Contact Person: Melissa E Nagelin, Ph.D.,
Adan Cajina, Chief, Demonstration
will be inspected before being allowed on Scientific Review Officer, Office of Scientific
Evaluation Branch, Office of Training
campus. Visitors will be asked to show one Review/DERA, National Heart, Lung, and
and Capacity Development, Division of
form of identification (for example, a Blood Institute, 6701 Rockledge Drive, Room
HIV Domestic Programs, HIV/AIDS government-issued photo ID, driver’s license, 7202, Bethesda, MD 20892, 301–435–0297,
Bureau, HRSA, 5600 Fishers Lane, or passport) and to state the purpose of their nagelinmh2@nhlbi.nih.gov.
09N108, Rockville, MD 20857, Phone: visit. (Catalogue of Federal Domestic Assistance
(301) 443–3180, Email: acajina@ Information is also available on the Program Nos. 93.233, National Center for
hrsa.gov. Institute’s/Center’s home page: http:// Sleep Disorders Research; 93.837, Heart and
Dated: September 19, 2017. deainfo.nci.nih.gov/advisory/fac/fac.htm, Vascular Diseases Research; 93.838, Lung
George Sigounas, where an agenda and any additional Diseases Research; 93.839, Blood Diseases
information for the meeting will be posted and Resources Research, National Institutes
Administrator. of Health, HHS)
[FR Doc. 2017–20544 Filed 9–25–17; 8:45 am] when available.
(Catalogue of Federal Domestic Assistance Dated: September 20, 2017.
BILLING CODE 4165–15–P
Program Nos. 93.392, Cancer Construction; Michelle Trout,
93.393, Cancer Cause and Prevention Program Analyst, Office of Federal Advisory
DEPARTMENT OF HEALTH AND Research; 93.394, Cancer Detection and Committee Policy.
HUMAN SERVICES Diagnosis Research; 93.395, Cancer [FR Doc. 2017–20489 Filed 9–25–17; 8:45 am]
Treatment Research; 93.396, Cancer Biology BILLING CODE 4140–01–P
National Institutes of Health Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
National Cancer Institute; Notice of Cancer Control, National Institutes of Health, DEPARTMENT OF HEALTH AND
Meeting HHS) HUMAN SERVICES
Pursuant to section 10(d) of the Dated: September 20, 2017. National Institutes of Health
Federal Advisory Committee Act, as Melanie J. Pantoja,
amended, notice is hereby given of a Center for Scientific Review; Notice of
Program Analyst, Office of Federal Advisory
meeting of the Frederick National Committee Policy. Closed Meetings
Laboratory Advisory Committee to the
[FR Doc. 2017–20487 Filed 9–25–17; 8:45 am]
National Cancer Institute. Pursuant to section 10(d) of the
The meeting will be open to the BILLING CODE 4140–01–P Federal Advisory Committee Act, as
public, with attendance limited to space amended, notice is hereby given of the
available. Individuals who plan to following meetings.
attend and need special assistance, such The meetings will be closed to the
as sign language interpretation or other public in accordance with the

VerDate Sep<11>2014 18:28 Sep 25, 2017 Jkt 241001 PO 00000 Frm 00063 Fmt 4703 Sfmt 4703 E:\FR\FM\26SEN1.SGM 26SEN1

Document Created: 2017-09-26 02:48:54
Document Modified: 2017-09-26 02:48:54

Category		Regulatory Information
Collection		Federal Register
sudoc Class		AE 2.7: GS 4.107: AE 2.106:
Publisher		Office of the Federal Register, National Archives and Records Administration
Section		Notices
Dates		October 17, 2017.
FR Citation		82 FR 44821

82 FR 44821 - National Heart, Lung, and Blood Institute; Notice of Closed Meeting

DEPARTMENT OF HEALTH AND HUMAN SERVICESNational Institutes of Health

Federal Register Volume 82, Issue 185 (September 26, 2017)

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health